Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-911543 in Myelofibrosis
NCT01236352Phase 2Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2011
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of BMS-911543 in myelofibrosis (MF), sponsored by Bristol Myers Squibb. Started Apr 2011; status: terminated.
02
Drugs
BMS-911543
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT01236352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01236352.